Palvella Therapeutics GAAP EPS of -$7.83
Seeking Alpha News (Mon, 31-Mar 8:23 AM)
- Palvella Therapeutics press release (NASDAQ:PVLA): FY GAAP EPS of -$7.83.
- Cash and cash equivalents of over $83 million as of December 31, 2024 expected to fund operations into the second half of 2027
